(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Momentum: Holley and LifeMD Surge On Upbeat Earnings

August 10th, 2023

Holley Inc. (NYSE: HLLY), a leading manufacturer of high-performance automotive components, reported second-quarter 2023 earnings of $0.14 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales reached $175.26 millio. Read more

Breaking: Edible Garden Beats Estimates; Bullish Stance on Zai Lab

August 10th, 2023

Edible Garden AG Incorporated (Nasdaq: EDBL), a provider of fresh herbs and produce, reported a second-quarter 2023 loss of $(0.24) per share, better than the consensus estimate loss of $(0.90). The company's quarterly sales amounted to $4.22 million. Read more

Earnings Roundup: Alibaba Beats, Six Flags Disappoints

August 10th, 2023

Alibaba Group Holding Limited (NYSE: BABA), a global technology and e-commerce giant, reported first-quarter fiscal-year 2024 earnings of $2.40 per share, surpassing the consensus EPS estimate of $2.02. The company's quarterly sales stood at $32.29 b. Read more

Vistagen Therapeutics Gains Momentum; Blend Labs Beats Estimates

August 10th, 2023

Shares of Vistagen Therapeutics, Inc. (Nasdaq: VTGN) surged over 20% in after-hours trading as Commodore Capital LP disclosed in a regulatory filing (Form 4) with the SEC that it has recently acquired 775,756 shares of Vistagen through multiple trans. Read more

Market Shift: AppLovin's Upbeat Earnings, Lockheed Martin's $30M+ Contract

August 09th, 2023

AppLovin Corporation (Nasdaq: APP) reported second quarter 2023 earnings of $0.22 per share, surpassing the consensus EPS estimate of $0.07. Additionally, the company achieved quarterly sales of $750.16 million, exceeding the analysts' forecasted rev. Read more

Breaking: Galera Therapeutics Tumbles on FDA Setback

August 09th, 2023

Shares of Galera Therapeutics, Inc.? (Nasdaq: GRTX) plunged over 70% in after-hours trading as the company received a Complete Response Letter (CRL) from the FDA, addressing its New Drug Application (NDA) for avasopasem manganese, a potential treatme. Read more

AI Cyber Challenge: Biden-Harris Admin Takes Action to Protect America's Critical Software

August 09th, 2023

In a strategic move to bolster cybersecurity, the Biden-Harris Administration has introduced the "AI Cyber Challenge" (AIxCC), a two-year competition focused on fortifying critical software using artificial intelligence (AI). Led by DARPA and joined . Read more

Breaking: Carvana Boosts Outlook; Bullish View On RAPT Therapeutics

August 09th, 2023

Shares of Carvana Co. (NYSE: CVNA) surged over 5% in pre-market trading following its announcement of an enhanced Q3 2023 outlook. The improvement is attributed to significant advancements in key business drivers and strong early-quarter momentum. . Read more

GoodRx and GEO Group Top Expectations, Outlook Miss

August 09th, 2023

GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projec. Read more

Earnings Spotlight: Rapid7 Outperforms Estimates, Hyliion Falls Short

August 09th, 2023

Cybersecurity firm Rapid7, Inc. (Nasdaq: RPD) released its second-quarter 2023 financial report, disclosing earnings of $0.18 per share, exceeding the consensus EPS estimate of $0.11. The company's quarterly sales amounted to $190.42 million, slightl. Read more